A pharmacopoeial HPLC assay was validated before it was published, and it has never seen your placebo.
That is the gap behind "it's a compendial method, we can use it as it is". EU GMP Chapter 6 says testing methods should be validated, and that a laboratory using a method it did not originally validate should verify the appropriateness of the testing method.
WHO's validation guideline goes further. When pharmacopoeial methods are used, evidence should be available to prove that they are suitable for routine use in the laboratory. Methods for content or impurities should also have been demonstrated to be specific for the product under consideration, with no placebo interference. And it describes verification as partial validation: the characteristics are selected according to the procedure and its intended use, and the selection should be justified.
Passing system suitability on the day is a narrower thing. It shows the instrument and column were working for that run.
How much verification is enough depends on the method. A pH test needs far less than a related-substances method on a product with five excipients.
Topics
Industries



